» Articles » PMID: 23209855

Transcriptional Profiling of the Bladder in Urogenital Schistosomiasis Reveals Pathways of Inflammatory Fibrosis and Urothelial Compromise

Overview
Date 2012 Dec 5
PMID 23209855
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Urogenital schistosomiasis, chronic infection by Schistosoma haematobium, affects 112 million people worldwide. S. haematobium worm oviposition in the bladder wall leads to granulomatous inflammation, fibrosis, and egg expulsion into the urine. Despite the global impact of urogenital schistosomiasis, basic understanding of the associated pathologic mechanisms has been incomplete due to the lack of suitable animal models. We leveraged our recently developed mouse model of urogenital schistosomiasis to perform the first-ever profiling of the early molecular events that occur in the bladder in response to the introduction of S. haematobium eggs. Microarray analysis of bladders revealed rapid, differential transcription of large numbers of genes, peaking three weeks post-egg administration. Many differentially transcribed genes were related to the canonical Type 2 anti-schistosomal immune response, as reflected by the development of egg-based bladder granulomata. Numerous collagen and metalloproteinase genes were differentially transcribed over time, revealing complex remodeling and fibrosis of the bladder that was confirmed by Masson's Trichrome staining. Multiple genes implicated in carcinogenesis pathways, including vascular endothelial growth factor-, oncogene-, and mammary tumor-related genes, were differentially transcribed in egg-injected bladders. Surprisingly, junctional adhesion molecule, claudin and uroplakin genes, key components for maintaining the urothelial barrier, were globally suppressed after bladder exposure to eggs. This occurred in the setting of urothelial hyperplasia and egg shedding in urine. Thus, S. haematobium egg expulsion is associated with intricate modulation of the urothelial barrier on the cellular and molecular level. Taken together, our findings have important implications for understanding host-parasite interactions and carcinogenesis in urogenital schistosomiasis, and may provide clues for novel therapeutic strategies.

Citing Articles

Effects of Schistosoma haematobium infection and treatment on the systemic and mucosal immune phenotype, gene expression and microbiome: A systematic review.

Mertelsmann A, Bowers S, Wright D, Maganga J, Mazigo H, Ndhlovu L PLoS Negl Trop Dis. 2024; 18(9):e0012456.

PMID: 39250522 PMC: 11412685. DOI: 10.1371/journal.pntd.0012456.


RNA-seq gene expression profiling of the bladder in a mouse model of urogenital schistosomiasis.

Ishida K, Osakunor D, Rossi M, Lamanna O, Mbanefo E, Cody J bioRxiv. 2024; .

PMID: 38979184 PMC: 11230422. DOI: 10.1101/2024.06.29.601185.


Urine microbiome in individuals with an impaired immune system.

Elsayed N, Wolfe A, Burk R Front Cell Infect Microbiol. 2024; 13:1308665.

PMID: 38274734 PMC: 10808152. DOI: 10.3389/fcimb.2023.1308665.


Frequency distribution of cytokine and associated transcription factor single nucleotide polymorphisms in Zimbabweans: Impact on schistosome infection and cytokine levels.

Hanton A, Scott F, Stenzel K, Nausch N, Zdesenko G, Mduluza T PLoS Negl Trop Dis. 2022; 16(6):e0010536.

PMID: 35759449 PMC: 9236240. DOI: 10.1371/journal.pntd.0010536.


Exploring the role of macrophages in determining the pathogenesis of liver fluke infection.

Quinteros S, OBrien B, Donnelly S Parasitology. 2022; 149(10):1364-1373.

PMID: 35621040 PMC: 11010472. DOI: 10.1017/S0031182022000749.


References
1.
Choi S, Byun Y, Lee G . Expressions of uroplakins in the mouse urinary bladder with cyclophosphamide-induced cystitis. J Korean Med Sci. 2009; 24(4):684-9. PMC: 2719198. DOI: 10.3346/jkms.2009.24.4.684. View

2.
Vuong P, Bayssade-Dufour C, Albaret J, Farhati K . Histopathological observations in new and classic models of experimental Schistosoma haematobium infections. Trop Med Int Health. 1996; 1(3):348-58. DOI: 10.1046/j.1365-3156.1996.d01-52.x. View

3.
Mentink-Kane M, Cheever A, Thompson R, Hari D, Kabatereine N, Vennervald B . IL-13 receptor alpha 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasis. Proc Natl Acad Sci U S A. 2003; 101(2):586-90. PMC: 327191. DOI: 10.1073/pnas.0305064101. View

4.
Visnjar T, Kocbek P, Kreft M . Hyperplasia as a mechanism for rapid resealing urothelial injuries and maintaining high transepithelial resistance. Histochem Cell Biol. 2011; 137(2):177-86. DOI: 10.1007/s00418-011-0893-0. View

5.
Bedwani R, Renganathan E, El Kwhsky F, Braga C, Abu Seif H, Abul Azm T . Schistosomiasis and the risk of bladder cancer in Alexandria, Egypt. Br J Cancer. 1998; 77(7):1186-9. PMC: 2150141. DOI: 10.1038/bjc.1998.197. View